Aptamer-immobilized bone-targeting nanoparticles in situ reduce sclerostin for osteoporosis treatment
Yuting Niu, Yang Yang, Zhèn Yáng, Xu Wang, Ping Zhang, Longwei Lv, Yan Liu, Yunsong Liu, Yongsheng Zhou
Topics & Concepts
SclerostinOsteoporosisNanomedicineChemistryDrug deliveryIn vivoOvariectomized ratPharmacologyMedicineNanoparticleInternal medicineMaterials scienceNanotechnologyBiochemistryBiologyGeneWnt signaling pathwayHormoneBiotechnologyOrganic chemistryBone health and treatmentsBone and Joint DiseasesAdvanced biosensing and bioanalysis techniques